Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) Research & Development: 2022-2023

Historic Research & Development for Lexeo Therapeutics (LXEO) over the last 1 years, with Dec 2023 value amounting to $8.2 million.

  • Lexeo Therapeutics' Research & Development fell 27.90% to $8.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $53.1 million, marking a year-over-year change of. This contributed to the annual value of $74.1 million for FY2024, which is 39.45% up from last year.
  • As of Q4 2023, Lexeo Therapeutics' Research & Development stood at $8.2 million, which was down 52.39% from $17.2 million recorded in Q3 2023.
  • In the past 5 years, Lexeo Therapeutics' Research & Development ranged from a high of $17.2 million in Q3 2023 and a low of $8.2 million during Q4 2023.
  • Moreover, its 2-year median value for Research & Development was $13.4 million (2022), whereas its average is $13.3 million.
  • Over the last 5 years, Lexeo Therapeutics' Research & Development had its largest YoY gain of 12.26% in 2023, and its largest YoY loss of 27.90% in 2023.
  • Lexeo Therapeutics' Research & Development (Quarterly) stood at $11.4 million in 2022, then fell by 27.90% to $8.2 million in 2023.
  • Its last three reported values are $8.2 million in Q4 2023, $17.2 million for Q3 2023, and $11.2 million during Q2 2023.